RUBRYC THERAPEUTICS Trademark

Trademark Overview

On Monday, April 2, 2018, a trademark application was filed for RUBRYC THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the RUBRYC THERAPEUTICS trademark a serial number of 87860305. The federal status of this trademark filing is REGISTERED as of Tuesday, August 10, 2021. This trademark is owned by Rubryc Therapeutics, Inc.. The RUBRYC THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

research and development regarding pharmaceuticals, proteins, and antibodies; platform-as-a-service (PaaS) providing a platform for protein analysis and discovery of antibody-based drugs
rubryc therapeutics

General Information

Serial Number87860305
Word MarkRUBRYC THERAPEUTICS
Filing DateMonday, April 2, 2018
Status700 - REGISTERED
Status DateTuesday, August 10, 2021
Registration Number6449143
Registration DateTuesday, August 10, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 11, 2018

Trademark Statements

Amendment to a Registration/Renewal CertificateIssue New Certificate to: IBIO, INC (Delaware, Corporation) 8800 HSC PARKWAY BRYAN, Texas 77807.
NOT AVAILABLE"THERAPEUTICS"
Goods and Servicesresearch and development regarding pharmaceuticals, proteins, and antibodies; platform-as-a-service (PaaS) providing a platform for protein analysis and discovery of antibody-based drugs

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 10, 2018
Primary Code042
First Use Anywhere DateFriday, April 2, 2021
First Use In Commerce DateFriday, April 2, 2021

Trademark Owner History

Party NameIBIO, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBRYAN, TX 77807
Party NameRubryc Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameRubryc Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Carlos, CA 94070
Party NameRubryc Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Ramon, CA 94582

Trademark Events

Event DateEvent Description
Monday, May 17, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, March 16, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 13, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 23, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, March 16, 2024AMENDMENT UNDER SECTION 7 - PROCESSED
Friday, November 15, 2024NEW CERTIFICATE UNDER SECTION 7 - PROCESSED
Friday, July 27, 2018EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 23, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, November 5, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, April 21, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, October 28, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, May 5, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, May 5, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, August 1, 2023TEAS SECTION 7 REQUEST RECEIVED
Friday, June 28, 2024TEAS SECTION 7 REQUEST RECEIVED
Monday, July 5, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 30, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 5, 2018NEW APPLICATION ENTERED
Tuesday, April 10, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 11, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 5, 2021USE AMENDMENT FILED
Tuesday, November 6, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 11, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 6, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, May 17, 2021STATEMENT OF USE PROCESSING COMPLETE
Friday, April 30, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 25, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 7, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 23, 2019SOU EXTENSION 1 FILED
Tuesday, November 5, 2019SOU EXTENSION 2 FILED
Tuesday, April 21, 2020SOU EXTENSION 3 FILED
Wednesday, May 5, 2021SOU EXTENSION 5 FILED
Tuesday, April 23, 2019SOU EXTENSION 1 GRANTED
Friday, July 27, 2018EXAMINERS AMENDMENT E-MAILED
Friday, July 27, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 10, 2021REGISTERED-PRINCIPAL REGISTER
Friday, July 27, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, August 22, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 21, 2020SOU EXTENSION 3 GRANTED
Wednesday, October 28, 2020SOU EXTENSION 4 GRANTED
Monday, May 17, 2021SOU EXTENSION 5 GRANTED
Friday, April 30, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 9, 2018ASSIGNED TO LIE
Wednesday, July 18, 2018ASSIGNED TO EXAMINER
Monday, July 5, 2021ASSIGNED TO EXAMINER
Wednesday, October 28, 2020SOU EXTENSION 4 FILED
Tuesday, November 5, 2019SOU EXTENSION 2 GRANTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, April 23, 2024NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Tuesday, December 10, 2024NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

Related Keywords

therapeutics rubryc platform analysis protein discovery antibody drugs based providing service regarding